Table of Content


Introduction
Amyloidosis - Overview
Amyloidosis - Therapeutics Development
Amyloidosis - Therapeutics Assessment
Amyloidosis - Companies Involved in Therapeutics Development
Amyloidosis - Drug Profiles
Amyloidosis - Dormant Projects
Amyloidosis - Discontinued Products
Amyloidosis - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Amyloidosis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021


List of Tables


Number of Products under Development for Amyloidosis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Companies, 2021 (Contd..3)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Amyloidosis - Pipeline by ADRx Inc, 2021
Amyloidosis - Pipeline by Akcea Therapeutics Inc, 2021
Amyloidosis - Pipeline by Alnylam Pharmaceuticals Inc, 2021
Amyloidosis - Pipeline by Amgen Inc, 2021
Amyloidosis - Pipeline by Attralus Inc, 2021
Amyloidosis - Pipeline by Auven Therapeutics Development Switzerland Sarl, 2021
Amyloidosis - Pipeline by BridgeBio Pharma Inc, 2021
Amyloidosis - Pipeline by Bristol-Myers Squibb Co, 2021
Amyloidosis - Pipeline by BSIM Therapeutics SA, 2021
Amyloidosis - Pipeline by Caelum Biosciences Inc, 2021
Amyloidosis - Pipeline by Chugai Pharmaceutical Co Ltd, 2021
Amyloidosis - Pipeline by Corino Therapeutics Inc, 2021
Amyloidosis - Pipeline by Covalent Bioscience Inc, 2021
Amyloidosis - Pipeline by EUSA Pharma (UK) Ltd, 2021
Amyloidosis - Pipeline by GlaxoSmithKline Plc, 2021
Amyloidosis - Pipeline by HaemaLogix Pty Ltd, 2021
Amyloidosis - Pipeline by IMMvention Therapeutix Inc, 2021
Amyloidosis - Pipeline by Johnson & Johnson, 2021
Amyloidosis - Pipeline by Mabpharm Ltd, 2021
Amyloidosis - Pipeline by Millennium Pharmaceuticals Inc, 2021
Amyloidosis - Pipeline by Neurimmune Holding AG, 2021
Amyloidosis - Pipeline by Oncopeptides AB, 2021
Amyloidosis - Pipeline by Precision Biosciences Inc, 2021
Amyloidosis - Pipeline by Proclara Biosciences Inc, 2021
Amyloidosis - Pipeline by Prothena Corp Plc, 2021
Amyloidosis - Pipeline by R Pharm, 2021
Amyloidosis - Pipeline by Regeneron Pharmaceuticals Inc, 2021
Amyloidosis - Pipeline by Sanofi, 2021
Amyloidosis - Pipeline by Sorrento Therapeutics Inc, 2021
Amyloidosis - Pipeline by Spectrum Pharmaceuticals Inc, 2021
Amyloidosis - Pipeline by Telix Pharmaceuticals Ltd, 2021
Amyloidosis - Pipeline by Vera Therapeutics Inc, 2021
Amyloidosis - Dormant Projects, 2021
Amyloidosis - Dormant Projects, 2021 (Contd..1)
Amyloidosis - Discontinued Products, 2021